Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus

AIM: To investigate the real-world efficacy and safety of sofosbuvir/ribavirin (SOF/RBV) therapy for Japanese patients with genotype 2 hepatitis C virus (GT2-HCV). METHODS: A total of 182 patients with GT2-HCV infection who received SOF/RBV therapy for 12 wk at our hospital were enrolled. The patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yada, Masayoshi, Miyazaki, Masayuki, Tanaka, Kosuke, Masumoto, Akihide, Motomura, Kenta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889827/
https://www.ncbi.nlm.nih.gov/pubmed/29632428
http://dx.doi.org/10.3748/wjg.v24.i13.1478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889827/
https://www.ncbi.nlm.nih.gov/pubmed/29632428
http://dx.doi.org/10.3748/wjg.v24.i13.1478

Ejemplares similares